1.Yinzhihuang Injection Combined Oxymatrine Injection for Acute Icteric Viral Hepatitis:Observation of Clinical Efficacy
China Pharmacy 2007;0(27):-
OBJECTIVE:To evaluate the efficacy of Yinzhihuang injection combined Oxymatrine injection for patients with acute icteric viral hepatitis.METHODS:100 patients with acute icteric viral hepatitis were randomly divided into two groups:50 patients in the the trial group were treated iv with Yinzhihuang injection 30 mL plus Oxymatrine sterile injection powder 600 mg qd for 30 days,and the another 50(control group) treated iv with Potassium magnesium aspartate 20 mL and Diammonium glycyrrhizinate injection 30 mL qd for 30 days.RESULTS:The cure rate and improvement rate in the trial group was signficantly higher than in the control group(P
2.Adenovirus-Mediated Vascular Targeting Suicide Gene Therapy in vitro
Lingfei XU ; Dehua XU ; Kai GE
Chinese Journal of Cancer Biotherapy 1995;0(03):-
To investigate the potential use of suicide gene systems in vascular targeting gene therapy, HSV-tk/GCV and EC-cd/5-FC systems were established on vascular endothelial cells in vitro by adenovirus transduction. Both modified cell lines were highly sensitive to prodrugs, the IC_(50) for GCV was 0.2?mol/L in IGll/Ad-tk cells, and IC_(50) for 5-FC was 20?mol/L in IGll/Ad-cd cells, while the parental endothelial cells were insensitive even at the highest concentrations of prodrugs in the experiment. Mixed cellular assay showed that significant bystander killing effect was exhibited in modified endothelial cells. Also, the apoptosis involved in these prodrug-mediated growth inhibitions has been shown under electron microscopy. These results indicated that both HSV-tk/GCV and EC-cd/5-FC systems could efficiently suppress vascular endothelial cell growth in vitro , suggesting the feasibility of using suicide gene in vascular targeting gene therapy.
3.The impact of cell period and cell surface antigen in cervical cancer cell lines by interferon-? gene transfer
Lei ZHANG ; Qiang DING ; Dehua XU
China Oncology 2001;0(03):-
Purpose:To explore the tumor cell responses after IFN-? gene transfer by analyzing the expression of cell surface antigen,apoptosis and the impact of cell period. Methods:We constructed IFN-? gene expression vector-pcDNA3- IFN-?, and transfected it into HeLa cell lines by Lipofectamine. The expression of IFN-??the Human Leukocyte antigen(HLA-DR) after gene transfer were measured. The apoptosis of tumor cells and the variety of cell period were also measured to investigate the anti-tumor mechanism by IFN-? gene therapy. Results:The results showed that the HLA-DR expression in Hela cell lines increased significantly(P
4.Clinical Observation of Qianggu Capsule Plus Alendronate on Postmenopausal Osteoporosis
Hong XU ; Dehua REN ; Zhu LIANG
Journal of Zhejiang Chinese Medical University 2006;0(04):-
[Objective] To investigate the effects of Qianggu capsule plus alendronate on postmenopausal osteoporosis.[Methods]By random number generating method,120 patients were randomly divided into a treatment group with Qianggu capsule plus alendronate,control group A only with Qianggu capsule,and control group B only with alendronate.The pain of the patient before treatment,3 m and 6 m after treatment was assessed.At the same time,the bone mineral density (BMD) before and 6 months after treatment was recorded.[Results] There was significant difference before and after 3 m in the score of pain in three groups,but the difference in treatment group was higher than other two control groups.After 6 m,all the scores of pain in 3 groups had changed significantly compared to the ones before treatment,but the scores of pain in treatment group were lower than 2 control groups.The BMD of both vertebral and ward in treatment group after 6 months treatment was higher than before.[Conclusions]Qianggu capsule plus alendronate has definite therapeutic effects on postmenopausal osteoporosis.
5.Serum Level of C Reactive Protein and Incidence of Sepsis in Patients with Severe Burn Treated with Xuebijing Injection
Dehua WANG ; Jihui XU ; Liang GAO
China Pharmacy 2005;0(21):-
OBJECTIVE: To observe the effects of Xuebijing injection on serum level of C reactive protein(CRP) and the incidence of sepsis in patients with severe burn.METHODS: Eighty cases with severe burn injury were randomly assigned to receive routine therapy alone(control group,n=40) routine therapy in combination with Xuebijing injection 100 mL q.d(treatment group,n=40) for 14 days.The level of CRP at 0,3,7,and 14 days were recorded and the incidences of sepsis in the two groups were analyzed statistically.RESULTS: At 7 days,the level of CRP in the treatment group was significantly lower than in the control group(P
6.Improvement of osseointegration of titanium dental implant by modified sandblasting surface treatment
Dehua LI ; Baolin LIU ; Jingcai ZOU ; Kewei XU
Journal of Practical Stomatology 2000;0(06):-
Objective:To study the effects of the modified sandblasting surface treatment on the bone implant interfacial shear strength of titanium dental implant.Methods:Titanium implants with smooth surface or modified sandblasted surface were inserted into femoral medialis condyli of dogs at random.The samples of implant with surrounding bone tissue were prepared in blockes and the shear strength of the interface was measured with Instron electronic pull out tester 2,4 and 12 weeks after operation. The modified sandblasted surface of the implant was observed with SEM and X ray spectroscopy 12 weeks after operation.Results:2 and 12 weeks after implantation the shear strength(MPa) between bone tissue and implants with modified sandblasted surface was 4.28?0.88 and 7.54?0.34 respectively,that between bone tissue and implants with smooth surface 0.09?0.08 and 1.43?0.46 respectively.SEM and X ray spectroscopy observation revealed that the most parts of the sandblasted surface of the implants were covered by bone tissue and bone matrix deposited into the pores created by the acid etching.Conclusion:The rough surface of titanium dental implant created by the modified sandblasting surface treatment can enhance the shear strength between bone tissue and implant.
7.Construction of database for clinical cases based on evidence-based medicine
Dehua YU ; Chengdong JI ; Chunbo LI ; Jiani XU
Chinese Journal of Medical Science Research Management 2014;27(2):205-208
Based on the background,conception and the core ideas of the evidence-based medicine,the construction and application of domestic clinical cases database was discussed.Problems concerning statistics,management and application in scientific research encountered in the database devel opment were presented,and suggestions were proposed.
8.A restrospective analysis of adverse events during peri-anesthesia period in patients scheduled for thoracic surgery
Meiying XU ; Xiaofeng ZHANG ; Dehua WU ; Dongjin WU ; Jingxiang WU
Chinese Journal of Anesthesiology 2014;34(9):1037-1040
From August 2006 to June 2011 among consecutive 18 294 patients underwent thoracic surgery from Shanghai Chest Hospital,41 developed adverse events during peri-anesthesia period and the incidence was 0.224%,and the constituent ratios of the predictable and unpredictable events were 15% and 85%,respectively.Cardiac arrest and massive hemorrhage were the main clinical manifestation of the adverse events and the constituent ratios were 37% and 24%,respectively.Among the inducements for adverse events,patient's factor,surgical factor,anesthesia factor,patient-surgery factor,patient-anesthesia factor and patient-surgery-anesthesia factor accounted for 12.2%,48.8%,12.2%,7.3%,7.3% and 12.2%,respectively.The ratio of death from adverse events was 17% (7 cases),and among the inducements for adverse events causing death,surgical factor,patient-surgery factor and patient-surgery-anesthesia factor accounted for 43%,43% and 14%,respectively.The incidence of adverse events was 1.093% in the patients underwent operation on trachea,which was significantly higher than that in the patients underwent operation on lung (0.223%),mediastinum (0.236%) and esophagus (0.194%).In conclusion,although the adverse events which occurred during peri-anesthesia period in the patients underwent thoracic surgery were rare,they threatened the safety of patients.Surgical factor was not only the main inducement,but also the risk factor for death,and cardiac arrest and massive hemorrhage were the main clinical manifestation of the surgery-related adverse events.For cardiac arrest,as long as it was found in time and treated appropriately,the serious consequences could be avoided.For massive hemorrhage,more attention should be paid due to be the main reason of death,and the prevention depended on the surgeon's improvement of diagnosis and surgery.It was difficult to predict patient-related the adverse events and careful monitoring was required.For the anesthesia-related adverse events,they were mostly due to the poor airway management,so preoperative airway assessment should be strengthened.
9.Analysis and evaluation of the effect of the implementation plan of personnel training in medical institutions
Chengdong JI ; Yun MIN ; Chang XU ; Pengfei WANG ; Dehua YU
Chinese Journal of Medical Science Research Management 2015;28(2):183-187,封4
Objective To establish an evaluation system to assess the effect of personnel training program for health professionals in the hospital,in order to achieve the goal that improve the overall competitiveness of the hospital.Methods Comparing and analyzing the differences in research project,research achievements,personnel capacity building before and after implementation of the training program.Paired T-test was used to exam the differences.Results There are statistically significant differences for proposed analyses (p ≤ 0.05).Conclusions The outcome of this study indicates that the personnel training program is extremely important to further development of the hospital.
10.Efficacy of strategy of optimizing anesthetic management in preventing occurrence of cardiac arrest during thoracic surgery
Dehua WU ; Jingya MA ; Hongwei ZHU ; Jingxiang WU ; Meiying XU
Chinese Journal of Anesthesiology 2016;36(11):1333-1336
The strategy of optimizing anesthetic management was carried out in all the patients un?dergoing thoracic surgery in our hospital from January 1, 2012: the patients were monitored using routine electrocardiogram combined with invasive arterial blood pressure monitoring, double?lumen central venous catheter pathway was established, and when severe bradycardia ( heart rate<40 beats∕min) occurred, inter?vention was carried out immediately, and chest compression was performed timely. Medical records of 15 212 patients from July 1, 2006 to December 31, 2011 ( before optimizing anesthetic management) as well as medical records of 17 078 patients from January 1, 2012 to January 15, 2015 ( after optimizing an?esthetic management) were reviewed. The data including baseline patient characteristics as well as the time period and causes of cardiac arrest, rescue time, rescue measures, successful resuscitation and prognosis in the patients developing intraoperative cardiac arrest were collected. Before optimizing anesthetic manage?ment, 28 patients developed cardiac arrest, the incidence was 0?184%, successful resuscitation was found in 25 cases, the success rate of resuscitation was 89%, and there were 3 cases in whom resuscitation failed due to massive hemorrhage?induced cardiac arrest. After optimizing anesthetic management, 17 patients de?veloped cardiac arrest, the incidence was 0?109%, massive hemorrhage?induced cardiac arrest was not found in patients, and the success rate of resuscitation was 100%. Prognosis was good after surgery in suc?cessfully resuscitated patients. Compared with the values before optimizing anesthetic management, the in?cidence of cardiac arrest was significantly decreased (P=0?05), and no significant change was found in the other parameters after optimizing anesthetic management ( P>0?05) , and the incidence of cardiac arrest was decreased by 45% after optimizing anesthetic management. In conclusion, the strategy of optimizing anesthetic management is helpful in decreasing the occurrence of cardiac arrest during thoracic surgery.